<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fresh-frozen human liver tissue was assayed for its ability to reduce the <z:chebi fb="0" ids="29785">nitrogroup</z:chebi> of R--<z:chebi fb="4" ids="16301,29423,29424,29785,29786,33101">NO2</z:chebi> to the <z:chebi fb="39" ids="32952">amine</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 10 livers examined exhibited demonstrable reductase activity </plain></SENT>
<SENT sid="2" pm="."><plain>The reduction was potentiated by <z:chebi fb="1" ids="16474">NADPH</z:chebi> and abolished by boiling the liver homogenates </plain></SENT>
<SENT sid="3" pm="."><plain>The nitroreductase activity varied among the different livers by as much as severalfold </plain></SENT>
<SENT sid="4" pm="."><plain>These findings show that ability of the human liver to reduce R--<z:chebi fb="4" ids="16301,29423,29424,29785,29786,33101">NO2</z:chebi> and support the hypothesis that certain toxic intermediates of the nitroreduction of R--<z:chebi fb="4" ids="16301,29423,29424,29785,29786,33101">NO2</z:chebi> may be responsible for the <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> associated with this drug </plain></SENT>
</text></document>